4.4 Article

Compositional variation of the human fecal microbiome in relation to azo-reducing activity: a pilot study

期刊

GUT PATHOGENS
卷 13, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13099-021-00454-0

关键词

Azoreductase; Gut microbiota; Firmicutes; Bacteroidetes; 16S rRNA; Pharmacomicrobiomics

资金

  1. Egyptian Academy of Scientific Research and Technology (ASRT) JESOR program [3046]

向作者/读者索取更多资源

This study found that stool samples with higher azo-reducing activity were enriched in Firmicutes but with relatively fewer Bacteroidetes. Multivariate analysis confirmed the Firmicutes proportion as a major variable distinguishing high and non-azo-reducers. More samples and studies from different geographical areas are needed to support this conclusion.
Background Through an arsenal of microbial enzymes, the gut microbiota considerably contributes to human metabolic processes, affecting nutrients, drugs, and environmental poisons. Azoreductases are a predominant group of microbiota-derived enzymes involved in xenobiotic metabolism and drug activation, but little is known about how compositional changes in the gut microbiota correlate with its azo-reducing activity. Results To this end, we used high-throughput 16S rRNA amplicon sequencing, with Illumina MiSeq, to determine the microbial community composition of stool samples from 16 adults with different azo-reducing activity. High azo-reducing activity positively correlated with the relative abundance of phylum Firmicutes (especially genera Streptococcus and Coprococcus) but negatively with phylum Bacteroidetes (especially genus Bacteroides). Typical variations in the Firmicutes-to-Bacteroidetes and Prevotella-to-Bacteroides ratios were observed among samples. Multivariate analysis of the relative abundance of key microbial taxa and other diversity parameters confirmed the Firmicutes proportion as a major variable differentiating high and non-azo-reducers, while Bacteroidetes relative abundance was correlated with azo-reduction, sex, and BMI. Conclusions This pilot study showed that stool samples with higher azo-reducing activity were enriched in Firmicutes but with relatively fewer Bacteroidetes. More samples and studies from different geographical areas are needed to bolster this conclusion. Better characterization of different azoreductase-producing gut microbes will increase our knowledge about the fate and differential human responses to azodye-containing drugs or orally consumed chemicals, thus contributing to efforts towards implementing microbiome testing in precision medicine and toxicology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据